• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THORATEC CORPORATION HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM; VENTRICULAR (ASSIST) BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THORATEC CORPORATION HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM; VENTRICULAR (ASSIST) BYPASS Back to Search Results
Model Number 106524
Device Problems Adverse Event Without Identified Device or Use Problem (2993); No Apparent Adverse Event (3189)
Patient Problem Unspecified Infection (1930)
Event Date 05/01/2021
Event Type  Injury  
Event Description
The date of the event is approximate as the data was collected between (b)(6) 2018 and (b)(6) 2021.It was reported through the research article ¿novel plug device for heartmate 3 explantation: first multicenter experience¿ that heartmate 3 (hm3) may be associated with infection and suction events.This retrospective study followed patients who had their hm3 explanted between (b)(6) 2018 and (b)(6) 2021.Several patients had complications while on left ventricular assist device (lvad) support prior to their explant.One of these patients was a 73-year-old man that had a previous lvad-related infection.After 22 months of hm3 support, the patient experienced suction events.A right heart catheterization (rhc) and echocardiography were performed.The patient underwent a device explant and was implanted with a novel apical ring plug for myocardial recovery.
 
Manufacturer Narrative
Specific patient information and device serial number are documented as unknown.Device was implanted at time of event.Author information: mariani, silvia from the department of cardiothoracic, transplantation and vascular surgery, hannover medical school, hannover, germany., department of cardio-thoracic surgery, heart and vascular centre, maastricht university medical centre (mumc+), maastricht, netherlands.No further information was provided.A supplemental report will be submitted once the manufacturer's investigation is complete.
 
Manufacturer Narrative
Section a: hospital privacy policy prohibited the identification of the patient.Section b3: event date was estimated.Manufacturer's investigation conclusion: a direct correlation between the heartmate 3 lvas and the reported infection and suction events could not be determined through this evaluation.The heartmate 3 lvas instructions for use (ifu) (rev.G) and the heartmate 3 lvas patient handbook (rev.G) are currently available.Section 1 of the ifu, ¿introduction¿, lists infection, as an adverse event that may be associated with the use of the heartmate 3 left ventricular assist system.Care instructions in reference to preventing infection are provided throughout this ifu, including sections titled "caring for the driveline exit site" and "controlling infection." section 4 explains that pi events are assumed by the system during cases when there are sudden and substantial changes in the pulsatility index.These events are also referred to as pi events and may be initiated for reasons other than true pi events.Some reasons include sudden changes in a patient¿s volume status, arrhythmias, sudden changes in power, and sudden changes in pump speed.There are no audible alarms with a pi event.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM
Type of Device
VENTRICULAR (ASSIST) BYPASS
Manufacturer (Section D)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer (Section G)
THORATEC CORPORATION
6035 stoneridge drive
pleasanton CA 94588
Manufacturer Contact
bob fryc
6035 stoneridge drive
pleasanton, CA 94588
7818528204
MDR Report Key15075415
MDR Text Key296312246
Report Number2916596-2022-12334
Device Sequence Number1
Product Code DSQ
UDI-Device Identifier00813024013297
UDI-Public813024013297
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P160054
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Company Representative
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 10/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/21/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number106524
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received10/25/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age73 YR
Patient SexMale
-
-